2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma
April 9, 2019
Jonathan Harris and Drew Hillier
Westlaw Journal Pharmaceutical
Westlaw Journal Pharmaceutical published “2018 Year-End Roundup of Federal Circuit Obviousness Decisions in Biopharma,” authored by Axinn partner Jonathan Harris and associate Drew Hillier.
Click here to access the article.